*
After approval by the local ethics committee (REC 10/H0703/71), written informed consent was obtained for use of macroscopically-normal ascending and descending/sigmoid (referred to hereon as descending) colon (5-10 cm from tumour) from patients undergoing elective surgery for non-obstructing bowel cancer. Patient records were examined for use of ongoing medication and evidence of comorbidity but a systematic survey of bowel functions (e.g. stool output/frequency) was not conducted. No patient had previous chemo-or radiotherapy or a diagnosis of inflammatory bowel disease. The time between surgery and immersion of tissue into pre-oxygenated Krebs solution was between 60 and 120 min. Tissues were separated into two discontinuous age groups: Adult (35-60 years) and Elderly (≥70 years).
After removing the mucosa, strips were cut parallel to the circular muscle (~5mm wide, 10-15mm long; 3-31 from each patient) and mounted in warmed tissue baths containing Krebs solution (mmolL-1: NaCl 121.5, CaCl 2 2.5, KH 2 PO 4 1.2, KCl 4.7, MgSO 4 1.2, NaHCO 3 25, glucose 5.6, equilibrated with 5% CO 2 /95% O 2 ) for measuring isometric muscle tension. Electrical field stimulation (EFS) was applied at 5 Hz and at 50V for 10s every 1 min to evoke neuronally-mediated responses (sensitive to prevention by tetrodotoxin 1 µM) in ascending and descending colon from adult (35 to 60 years) and elderly (≥ 70 years) patients.
Results
The figure shows the change in response during EFS after application of L-NAME 300 µM, in each region of adult (35 -6 (≥ 70 years; ) colon, for each tissue tested. The data are expressed as the change in g tension/ g wet weight of tissue, generated during EFS, together with the mean ± S.E.M. contractile force. Respectively, N = 14, 25, 16 and 23 in adult ascending, elderly ascending, adult descending and elderly descending colon. * represents P < 0.05 only where indicated.
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